VaccineHumansFemaleChildAntibodiesViral
Long term immunogenicity of two doses of the quadrivalent HPV vaccine and the effect of an additional dose given five years post-primary vaccination.
Chantal Sauvageau, Iulia Gabriela Ionescu, Manale Ouakki, Gitika Panicker, Elizabeth R Unger, Vladimir Gilca, Marie-Hélène Mayrand
Published: 202510.1016/j.vaccine.2025.127893
Abstract
BACKGROUND: Antibody persistence in girls (age 9-11 years) receiving two quadrivalent vaccine (4vHPV) doses and impact of an additional dose five years post-primary vaccination were assessed. METHODS: Girls vaccinated with two 4vHPV (Gardasil) doses…
Preview only. Read the full abstract at the source